These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20774947)

  • 1. Observations on THE RELATION OF MALIGNANT DISEASE TO BENIGN TUMOURS OF THE INTESTINAL TRACT.
    Stewart MJ
    Br Med J; 1929 Sep; 2(3586):567-9. PubMed ID: 20774947
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood supply of malignant and benign tumors of the internal genitals].
    Sohn C; Meyberg G; von Fournier D; Bastert G
    Geburtshilfe Frauenheilkd; 1993 Jun; 53(6):395-9. PubMed ID: 8330713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of prostacyclin (PGI2) and thromboxane A2 (TXA2) by vessels draining and not-draining benign and malignant tumours of the breast.
    Benedetto C; Barbero M; Rey L; Petitti E; Baccarini G; Ghiringhello B; Massobrio M; Slater TF
    Prostaglandins Leukot Med; 1985 Jan; 17(1):31-42. PubMed ID: 3883368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XIAP and Ki-67: A Correlation Between Antiapoptotic and Proliferative Marker Expression in Benign and Malignant Tumours of Salivary Gland: An Immunohistochemical Study.
    Bagulkar BB; Gawande M; Chaudhary M; Gadbail AR; Patil S; Bagulkar S
    J Clin Diagn Res; 2015 Feb; 9(2):EC01-4. PubMed ID: 25859460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibronectin in relation to growth patterns of fibrohistiocytic tumours--an immunohistochemical study of benign and malignant fibrous histiocytomas.
    Stiller D; Bahn H
    Acta Histochem; 1987; 82(1):95-108. PubMed ID: 2827424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Benign tumours of the intestinal tract (author's transl)].
    Ansorge D; Fiedler D; Voss J
    Zentralbl Chir; 1976; 101(20):1244-53. PubMed ID: 983469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profile of mucins (MUC1, MUC2, MUC5AC, and MUC6) in ovarian mucinous tumours: changes in expression from benign to malignant tumours.
    Wang J; El-Bahrawy M
    Histopathology; 2015 Mar; 66(4):529-35. PubMed ID: 25298197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestine-associated antigens in ovarian tumours: an immunohistological study.
    De Boer WG; Ma J; Nayman J
    Pathology; 1981 Jul; 13(3):547-55. PubMed ID: 7029434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of the cdx2 gene in benign intestinal-type mucinous ovarian tumors].
    Gaggero G; Sola S; Mora M; Fulcheri E
    Pathologica; 2003 Aug; 95(4):185-91. PubMed ID: 14577202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary tumours of the small bowel (author's transl)].
    Hildebrandt J
    Zentralbl Chir; 1978; 103(11):722-9. PubMed ID: 685540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of telomerase for the diagnosis of malignant well-differentiated endocrine tumours.
    Vezzosi D; Bouisson M; Escourrou G; Laurell H; Selves J; Seguin P; Pradayrol L; Caron P; Buscail L
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):63-7. PubMed ID: 16402930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phyllodes tumours of the breast: retrospective analysis of a University Hospital's experience.
    Toh YF; Cheah PL; Looi LM; Teoh KH; Tan PH
    Malays J Pathol; 2016 Apr; 38(1):19-24. PubMed ID: 27126660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG-PET/CT and FLT-PET/CT for differentiating between lipid-poor benign and malignant adrenal tumours.
    Nakajo M; Jinguji M; Fukukura Y; Kajiya Y; Tani A; Nakajo M; Nakabeppu Y; Arimura H; Nishio Y; Nakamura F; Yoshiura T
    Eur Radiol; 2015 Dec; 25(12):3696-705. PubMed ID: 25925356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of capsule-like rim enhancement on magnetic resonance imaging for distinguishing malignant from benign parotid tumours.
    Sakamoto M; Iikubo M; Kojima I; Sasano T; Mugikura S; Murata T; Watanabe M; Shiga K; Ogawa T; Takahashi S
    Int J Oral Maxillofac Surg; 2014 Sep; 43(9):1035-41. PubMed ID: 24703493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphometry and digital AgNOR analysis in cytological imprints of benign, borderline and malignant serous ovarian tumours.
    Stemberger-Papić S; Stanković T; Vrdoljak-Mozetic D; Versa-Ostojić D; Krasević M; Stifter S; Audy-Jurković S
    Cytopathology; 2006 Dec; 17(6):382-9. PubMed ID: 17168922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and cyst fluid levels of interleukin (IL) -6, IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumours.
    Daraï E; Detchev R; Hugol D; Quang NT
    Hum Reprod; 2003 Aug; 18(8):1681-5. PubMed ID: 12871882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of apoptosis-related proteins in endometriomas and benign and malignant ovarian tumours.
    Fauvet R; Poncelet C; Hugol D; Lavaur A; Feldmann G; Daraï E
    Virchows Arch; 2003 Jul; 443(1):38-43. PubMed ID: 12756564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation between malignant and benign follicular adnexal tumours of the skin by DNA image cytometry.
    Vogelbruch M; Rütten A; Böcking A; Kapp A; Kiehl P
    Br J Dermatol; 2002 Feb; 146(2):238-43. PubMed ID: 11903233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA Cytometry and Nuclear Morphometry in Ovarian Benign, Borderline and Malignant Tumors.
    El Din AA; Badawi MA; Aal SE; Ibrahim NA; Morsy FA; Shaffie NM
    Open Access Maced J Med Sci; 2015 Dec; 3(4):537-44. PubMed ID: 27275284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strain elastography features of epidermoid tumours in superficial soft tissue: differences from other benign soft-tissue tumours and malignant tumours.
    Park HJ; Lee SY; Lee SM; Kim WT; Lee S; Ahn KS
    Br J Radiol; 2015 Jun; 88(1050):20140797. PubMed ID: 25827206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.